Payment overview · 2025
General Payments
$47.98
1 reported records · 1 companies
Healthcare provider profile · identity verified
Randall L. Schaffner, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · VERNON, TX · NPI 1962400895
Verified facts
What the public records show
CMS Open Payments records show Randall L. Schaffner, M.D. received $47.98 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $47.98 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $47.98 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $47.98 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Potassium Chloride | Potassium Chloride | 642 | 90 |
| Levothyroxine Sodium | Levothyroxine Sodium | 570 | 80 |
| Losartan Potassium | Losartan Potassium | 445 | 61 |
| Pantoprazole Sodium | Pantoprazole Sodium | 410 | 76 |
| Amlodipine Besylate | Amlodipine Besylate | 358 | 63 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 297 | 30 |
| Gabapentin | Gabapentin | 289 | 36 |
| Furosemide | Furosemide | 271 | 44 |
| Atorvastatin Calcium | Atorvastatin Calcium | 221 | 41 |
| Montelukast Sodium | Montelukast Sodium | 218 | 35 |
| Telmisartan | Telmisartan | 201 | 32 |
| Metformin Hcl Er | Metformin Hcl | 182 | 29 |
| Metoprolol Succinate | Metoprolol Succinate | 180 | 25 |
| Alprazolam | Alprazolam | 174 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 170 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 159 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 158 | 22 |
| Allopurinol | Allopurinol | 155 | 21 |
| Glimepiride | Glimepiride | 148 | 22 |
| Lisinopril | Lisinopril | 147 | 23 |
| Tamsulosin Hcl | Tamsulosin Hcl | 138 | 25 |
| Clopidogrel | Clopidogrel Bisulfate | 137 | 19 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 136 | 24 |
| Ozempic | Semaglutide | 135 | 18 |
| Spironolactone | Spironolactone | 122 | 16 |
| Omeprazole | Omeprazole | 117 | 23 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 116 | 28 |
| Celecoxib | Celecoxib | 115 | 26 |
| Dexlansoprazole Dr | Dexlansoprazole | 113 | 15 |
| Donepezil Hcl | Donepezil Hcl | 111 | 16 |
| Tramadol Hcl | Tramadol Hcl | 107 | 24 |
| Memantine Hcl Er | Memantine Hcl | 103 | 12 |
| Alendronate Sodium | Alendronate Sodium | 100 | 11 |
| Famotidine | Famotidine | 99 | 25 |
| Carvedilol | Carvedilol | 97 | 15 |
| Eliquis | Apixaban | 93 | 15 |
| Nebivolol Hcl | Nebivolol Hcl | 93 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 91 | 11 |
| Ezetimibe | Ezetimibe | 90 | 15 |
| Simvastatin | Simvastatin | 89 | 16 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 88 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 86 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 84 | 18 |
| Cephalexin | Cephalexin | 83 | 58 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 83 | 13 |
| Cefdinir | Cefdinir | 78 | 58 |
| Januvia | Sitagliptin Phosphate | 75 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 73 | suppressed |
| Nabumetone | Nabumetone | 71 | suppressed |
| Chlorthalidone | Chlorthalidone | 69 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 69 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 67 | 22 |
| Glyxambi | Empagliflozin/Linagliptin | 67 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 65 | 13 |
| Dutasteride | Dutasteride | 65 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 65 | 14 |
| Lorazepam | Lorazepam | 65 | suppressed |
| Meloxicam | Meloxicam | 63 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 61 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 61 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 58 | 31 |
| Azithromycin | Azithromycin | 57 | 39 |
| Ropinirole Hcl | Ropinirole Hcl | 57 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 56 | suppressed |
| Temazepam | Temazepam | 56 | 11 |
| Xarelto | Rivaroxaban | 53 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 52 | 11 |
| Tramadol Hcl Er | Tramadol Hcl | 48 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 47 | 29 |
| Fluconazole | Fluconazole | 45 | 23 |
| Fentanyl | Fentanyl | 44 | suppressed |
| Finasteride | Finasteride | 44 | suppressed |
| Levofloxacin | Levofloxacin | 44 | 34 |
| Ramipril | Ramipril | 44 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 42 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 41 | 16 |
| Diazepam | Diazepam | 40 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 39 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | suppressed |
| Pregabalin | Pregabalin | 38 | suppressed |
| Tradjenta | Linagliptin | 38 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 37 | 22 |
| Estradiol | Estradiol | 37 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 37 | 23 |
| Carbamazepine | Carbamazepine | 36 | suppressed |
| Digoxin | Digoxin | 36 | suppressed |
| Etodolac | Etodolac | 36 | suppressed |
| Levetiracetam | Levetiracetam | 35 | suppressed |
| Prednisone | Prednisone | 34 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 34 | suppressed |
| Atenolol | Atenolol | 33 | suppressed |
| Metolazone | Metolazone | 33 | suppressed |
| Verapamil Er | Verapamil Hcl | 33 | suppressed |
| Dutasteride-Tamsulosin | Dutasteride/Tamsulosin Hcl | 32 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 32 | 21 |
| Zolpidem Tartrate | Zolpidem Tartrate | 32 | suppressed |
| Carisoprodol | Carisoprodol | 31 | suppressed |
| Jardiance | Empagliflozin | 30 | suppressed |
| Rybelsus | Semaglutide | 30 | suppressed |
| Lamotrigine | Lamotrigine | 29 | suppressed |
| Myrbetriq | Mirabegron | 29 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 29 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 29 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 28 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 28 | suppressed |
| Mupirocin | Mupirocin | 27 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 27 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 27 | suppressed |
| Acyclovir | Acyclovir | 26 | suppressed |
| Linzess | Linaclotide | 26 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 25 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 25 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 25 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 24 | suppressed |
| Febuxostat | Febuxostat | 24 | suppressed |
| Premarin | Estrogens, Conjugated | 24 | suppressed |
| Edarbi | Azilsartan Medoxomil | 23 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 23 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 22 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Valsartan | Valsartan | 22 | suppressed |
| Amlodipine-Olmesartan | Amlodipine Bes/Olmesartan Med | 21 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 21 | suppressed |
| Memantine Hcl | Memantine Hcl | 21 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 21 | suppressed |
| Mounjaro | Tirzepatide | 21 | suppressed |
| Synthroid | Levothyroxine Sodium | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Metformin Hcl | Metformin Hcl | 20 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 20 | suppressed |
| Movantik | Naloxegol Oxalate | 19 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 18 | suppressed |
| Methylprednisolone | Methylprednisolone | 18 | 17 |
| Mirtazapine | Mirtazapine | 18 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 18 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 17 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 15 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 15 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Nystatin | Nystatin | 15 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Glipizide Er | Glipizide | 14 | suppressed |
| Rifampin | Rifampin | 14 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 13 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 13 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 13 | suppressed |
| Gemtesa | Vibegron | 13 | suppressed |
| Haloperidol | Haloperidol | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Methocarbamol | Methocarbamol | 13 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Promethazine Hcl | Promethazine Hcl | 13 | suppressed |
| Rebif | Interferon Beta-1a/Albumin | 13 | suppressed |
| Torsemide | Torsemide | 13 | suppressed |
| Acebutolol Hcl | Acebutolol Hcl | 12 | suppressed |
| Ethambutol Hcl | Ethambutol Hcl | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Hysingla Er | Hydrocodone Bitartrate | 12 | suppressed |
| Invokana | Canagliflozin | 12 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 12 | suppressed |
| Mesalamine Er | Mesalamine | 12 | suppressed |
| Metronidazole | Metronidazole | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | suppressed |
| Qtern | Dapagliflozin/Saxagliptin Hcl | 12 | suppressed |
| Risedronate Sodium | Risedronate Sodium | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Tadalafil | Tadalafil | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 11 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 11 | suppressed |
| Glyburide | Glyburide | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Pentazocine-Naloxone Hcl | Pentazocine Hcl/Naloxone Hcl | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $47.98 · 1 records | AstraZeneca Pharmaceuticals LP | BREZTRI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error